Results 101 to 110 of about 84,234 (301)

The Effect of Olanzapine on Craving and Alcohol Consumption

open access: yes, 2006
Previous studies have indicated that olanzapine decreases craving after a priming dose of alcohol, that craving after a priming dose of alcohol is greater among individuals with the seven-repeat allele of the DRD4 variable number of tandem repeats (VNTR)
Davidson, Dena   +6 more
core  

Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Schizophrenia is regarded as a complex and heterogeneous psychiatric disorder, characterised by diverse symptoms and comorbidities, which complicate both clinical management and drug development. Current pharmacological treatment, primarily based on dopamine D2 receptor antagonism or partial agonism, which has not markedly progressed since the
Thi Viet Ha Nguyen   +2 more
wiley   +1 more source

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Comparative Study From Sudan

open access: yesJournal of Global Oncology, 2018
Purpose: Chemotherapy-induced nausea and vomiting (CINV) is a distressing adverse effect. Neurokinin-1 receptor antagonist (NK1RA)–containing regimens are the standard regimens for CINV prophylaxis in patients with cancer receiving highly or moderately ...
Alaa A.M. Osman   +7 more
doaj   +1 more source

Establishing gold standard approaches to rapid tranquillisation: a review and discussion of the evidence on the safety and efficacy of medications currently used [PDF]

open access: yes, 2008
Background: Rapid tranquillisation is used when control of agitation, aggression or excitement is required. Throughout the UK there is no consensus over the choice of drugs to be used as first line treatment.
Branford, David   +5 more
core   +1 more source

Exercise Protects Against Olanzapine-Induced Hyperglycemia in Male C57BL/6J Mice

open access: yesScientific Reports, 2018
Olanzapine is a widely prescribed antipsychotic drug. While effective in reducing psychoses, treatment with olanzapine causes rapid increases in blood glucose.
Laura N. Castellani   +4 more
semanticscholar   +1 more source

Perioperative Nivolumab in Resectable Non‐Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T

open access: yesCancer Science, EarlyView.
ABSTRACT In the randomized phase III CheckMate 77T study, perioperative nivolumab showed statistically significant and clinically meaningful improvement in event‐free survival (EFS) vs. placebo in patients with resectable, non‐metastatic non‐small cell lung cancer (NSCLC).
Fumihiro Tanaka   +17 more
wiley   +1 more source

Early Lipid Metabolic Effects of the Anti-Psychotic Drug Olanzapine on Weight Gain and the Associated Gene Expression

open access: yesNeuropsychiatric Disease and Treatment, 2022
Chien-Chih Chen,1,2 Toshiaki Nakano,3,4 Li-Wen Hsu,3,4 Chia Yi Chu,1 Kuang-Tzu Huang4,5 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan; 2School of Medicine, Chang Gung ...
Chen CC   +4 more
doaj  

Olanzapine: The game-changer “antiemetic”

open access: yesIndian Journal of Medical and Paediatric Oncology, 2019
Chemotherapy-induced nausea and vomiting (CINV) is significantly debilitating and worsens the quality of life. Olanzapine, an atypical antipsychotic drug, also has an antiemetic potential.
Manikandan Dhanushkodi
doaj   +1 more source

Alcohol addiction: a molecular biology perspective. [PDF]

open access: yes, 2015
Alcohol misuse represents worldwide an important risk factor for death and disability. Excessive alcohol consumption is widely diffused in different ethnicities and alcohol use is part of the lifestyle of both young and old people.
Ferraguti, Giampiero   +2 more
core   +1 more source

The Effect of Olanzapine through Antioxidant and Anti-Inflammation on the Hippocampus in the Asphyxial Cardiac Arrest Rat Model [PDF]

open access: green, 2023
Byung‐Yong Park   +13 more
openalex   +1 more source

Home - About - Disclaimer - Privacy